Computer-aided drug design and drug discovery: a prospective analysis

SK Niazi, Z Mariam - Pharmaceuticals, 2023 - mdpi.com
In the dynamic landscape of drug discovery, Computer-Aided Drug Design (CADD) emerges
as a transformative force, bridging the realms of biology and technology. This paper …

[HTML][HTML] A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19

SI Ahmed, S Jamil, H Ismatullah, R Hussain… - Saudi Journal of …, 2023 - Elsevier
COVID-19 is a pulmonary disease caused by SARS-CoV-2. More than 200 million
individuals are infected by this globally. Pyrexia, coughing, shortness of breath, headaches …

Computational design of phosphatidylinositol 3-kinase inhibitors

I Rani, A Goyal, M Sharma - ASSAY and Drug Development …, 2022 - liebertpub.com
One of the most sought-after therapeutic targets for treating human cancers is the
phosphoinositide 3-kinase; PI3k is an integral part of the PI3K/protein kinase B signaling …

Immunoinformatics design of B and T-cell epitope-based SARS-CoV-2 peptide vaccination

MS Khan, IM Khan, SU Ahmad, I Rahman… - Frontiers in …, 2023 - frontiersin.org
SARS-COV-2 is a virulent respiratory virus, first identified in China (Wuhan) at the end of
2019. Scientists and researchers are trying to find any possible solution to this deadly viral …

Gmx_qk: An automated protein/protein–ligand complex simulation workflow bridged to MM/PBSA, based on GROMACS and Zenity-Dependent GUI for beginners in …

H Singh, A Raja, A Prakash… - Journal of Chemical …, 2023 - ACS Publications
Open-source MD simulation tools provide academics and low-income countries with the
ability to compete in drug discovery advancements. Gromacs is a well-known and …

In-Silico Design, Synthesis, and Pharmacological Evaluation of Oxadiazole-Based Selective Cyclo-oxygenase-2 Inhibitors

M Kumar, I Rani, S Mujwar, R Narang… - ASSAY and Drug …, 2023 - liebertpub.com
A series of oxadiazole-based five-membered heterocyclic derivatives was designed and
synthesized with the intent of exclusive cyclo-oxygenase-2 (COX-2) inhibition to acquire anti …

[HTML][HTML] Identification of potential antiviral lead inhibitors against SARS-CoV-2 Main protease: structure-guided virtual screening, docking, ADME, and MD simulation …

G Lanka, R Bathula, B Ghosh, SR Potlapally - Artificial Intelligence …, 2023 - Elsevier
The novel coronavirus disease (COVID-19) was caused by a new strain of the virus SARS-
CoV-2 in December 2019 emerged as deadly pandemic that affected millions of people …

Virtual screening of natural compounds as potential SARS-CoV-2 main protease inhibitors: a molecular docking and molecular dynamics simulation guided approach

DK Lokwani, SR Chavan, AP Sarkate… - Chemistry …, 2023 - mdpi.com
The 2019 coronavirus (COVID-19) pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has significantly impacted human lives, overburdened the …

IN SILICO STUDIES OF SOME NEWLY DESIGNED BENZIMIDAZOLETHIAZOLIDINONE BASED ANTAGONISTS OF HUMAN ESTROGEN RECEPTOR.

J Monga, NS Ghosh, S Mujwar, I Rani - Indian Drugs, 2023 - search.ebscohost.com
Breast cancer is globally associated with majority of the women. Indeed, high estrogen
levels are the most common subtype of breast cancer. Three different classes of estrogen …

The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: a review

Z Alipour, S Zarezadeh, AA Ghotbi-Ravandi - Planta Medica, 2023 - thieme-connect.com
In early 2020, a global pandemic was announced due to the emergence of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), known to cause COVID-19. Despite …